All News

Brianna Hawkins, MBA, a University of Tennessee Health Science Center doctor of pharmacy candidate, discusses oncology drug development and how students can start a career in this alternative path.

Many long-term therapies rely solely on load amelioration, but new ones are needed, according to investigators.

Individuals who are rituximab-naïve remained stable after 2 years of follow-up, the analysis shows.

It would also be beneficial to include a patient’s entire healthcare team in this management strategy, said an expert at the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference 2023 in Phoenix, Arizona.

Part 1 of this 2-part series examines USP <797> and <795> revisions for sterile and nonsterile compounding, veterinary compounding, FDA inspections of 503A pharmacies, and the interstate distribution of compounded prescriptions post Wellness Pharmacy v. FDA.

Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.

Eye drops come in many forms and for many indications, such as redness, itchiness, dryness, allergies, dilating drops, glaucoma drops, lubricants, numbing agents, antibiotics, and to lower pressure.

Accelerated approvals for ibrutinib (Imbruvica) for patients with mantle cell lymphoma and with marginal zone lymphoma voluntarily withdrawn based on data that were insufficient to support conversion to full approval.

The patient had no significant past medical complications and was fully immunized for the age-based recommendation from the Advisory Council and Immunization Practices, study shows.

Consistent toxicity management and education reinforcement can improve the patient’s treatment management strategy.

Fellows tap into a network of experts, their practice sites, and countless tools they can apply immediately.

Among those without HIV, the analyses found that respondents with a history of COVID-19 performed worse on processing speed than those who had never had COVID-19.

The application is based on the PHAROS trial, which met its primary endpoint of objective response rate in patients with metastatic non–small cell lung cancer with a BRAF V600E mutation.

The disease is the continuation of new symptoms 3 months after the initial SARS-CoV-2 infection and at least lasting 2 months after infection, according to the health organization.

Jeffrey Bratberg, PharmD, FAPhA, a clinical professor for the college of pharmacy at the University of Rhode Island, discusses harm reduction and substance use disorder treatment.

Study results show significant differences in pCR rates, but the differences were not subtype-specific.

It is a means of supporting the growing provider status movement, which could enable clinical practice growth.

Expert discusses the updated guidelines for treating diabetes at the American Pharmacists Association (APhA) 2023 Meeting & Exposition in Phoenix, Arizona.

In the treatment of heart failure with reduced ejection fraction, combination therapy is the most effective in reducing all-cause death.

Improving patient safety and reducing harmful events is a team effort that includes both executive leadership and management as well as front line care teams.

As more drugs gain coverage, decision-makers will need to more accurately diagnose Alzheimer disease, especially in the community setting.

Students still have a myriad of career options, including at retail pharmacies, hospitals, and outside traditional practice.

Pharmacists are cited as one of the most stressed professions and a creative habit can help to improve focus, enhance productivity, and reduce stress.

Investigators analyze to see if there was an association of expected benefits and risk of vaccination.

Health benefits last for at least 5 years if shedding pounds occur via a lifestyle change program, the results of a research review show.

This drug is the first to control complement factor C5a, which is a protein that plays a significant but potentially harmful role in the body's immune response.

Data show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.

Implementing PrEP in retail community pharmacies increases patient accessibility but may be difficult to incorporate without modifying workflow.